Cytotoxic conjugates comprising a chemokine receptor targeting agent
Details for Australian Patent Application No. 2007201749 (hide)
International Classifications
Event Publications
10 May 2007 Application Open to Public Inspection
Published as AU-B-2007201749
10 May 2007 Complete Application Filed
29 May 2008 Application Accepted
Published as AU-B-2007201749
3 July 2008 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to read: FROM: Coggins, Phillip J. TO: Coggins, Philip J. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
14 August 2008 Assignment before Grant
Osprey Pharmaceuticals Limited The application has been assigned to Osprey Pharmaceuticals USA, Inc.
23 October 2008 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read FROM: Coggins, Phillip J. TO: Coggins, Philip J.
30 October 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007201748-Local regional chemotherapy and radiotherapy using in situ hydrogel
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser